Kenneth M Taylor
Overview
Explore the profile of Kenneth M Taylor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
911
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ai J, Hassink M, Taylor K, Kuklenyik P, Valentin-Blasini L, Watson C
Chem Res Toxicol
. 2024 Jan;
37(2):220-226.
PMID: 38235526
We measured levels of nitrosonornicotine (NNN) and 4-[methyl(nitroso)amino]-1-(3-pyridinyl)-1-butanone (NNK), the two most carcinogenic tobacco-specific nitrosamines, in the filler, binder, and wrapper of 50 cigars: 19 large cigars, 23 cigarillos, and...
2.
Jackson K, Schroeder M, Ai J, Taylor K, Oniyide O, Viray L, et al.
Nicotine Tob Res
. 2023 Jan;
25(6):1202-1206.
PMID: 36702747
Introduction: Studies have evaluated the role of menthol cigarettes on various addiction-related outcomes; however, the effect of varying menthol content on these outcomes has not been evaluated. We developed a...
3.
Edwards S, Hassink M, Taylor K, Vu A
Chem Res Toxicol
. 2023 Jan;
36(2):202-212.
PMID: 36638203
This study examined the variation of benzo[]pyrene (B[]P), '-nitrosonornicotine (NNN), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) levels in 16 smokeless tobacco products from several different product subcategories obtained at two different locations and...
4.
Edwards S, Hassink M, Taylor K, Watson C, Kuklenyik P, Wang L, et al.
Chem Res Toxicol
. 2022 Jun;
35(7):1131-1134.
PMID: 35738012
No abstract available.
5.
Edwards S, Hassink M, Taylor K, Vu A
Regul Toxicol Pharmacol
. 2022 Jun;
133:105199.
PMID: 35662636
Smokeless tobacco products expose adult and youth tobacco users to various addictive and carcinogenic constituents that can cause long-term nicotine dependence and oral cancers. In this study, nicotine, benzo[a]pyrene (B[a]P),...
6.
Ai J, Hassink M, Taylor K, Deycard V, Hearn B, Williams K, et al.
Chem Res Toxicol
. 2022 May;
35(6):940-953.
PMID: 35612471
Mainstream smoke yields of hydrogen cyanide (HCN) and three aromatic amines, 1-aminonaphthalene, 2-aminonaphthalene, and 4-aminobiphenyl, from 60 little cigar brands currently on the US market were measured for both International...
7.
Liu Y, Taylor K, Watson C, Valentin-Blasini L
Chem Res Toxicol
. 2021 Jul;
34(7):1713-1717.
PMID: 34228438
Two-tail test statistical analyses of International Organization for Standardization nonintense and Canadian Intense mainstream smoke yields of total particulate matter, tar, nicotine, and carbon monoxide from cigarettes show that mean...
8.
Edwards S, Hassink M, Taylor K, Watson C, Kuklenyik P, Kimbrell B, et al.
Chem Res Toxicol
. 2021 Mar;
34(4):1034-1045.
PMID: 33667338
Cigars are among the broad variety of tobacco products that have not been as extensively studied and characterized as cigarettes. Small cigars wrapped in a tobacco-containing sheet, commonly referred to...
9.
Vu A, Hassink M, Taylor K, McGuigan M, Blasiole A, Valentin-Blasini L, et al.
Chem Res Toxicol
. 2021 Jan;
34(3):704-712.
PMID: 33512154
The mainstream smoke yields of five volatile organic compounds (VOCs) were determined from 60 commercial U.S. little cigar products under ISO 3308 and Canadian Intense (CI) smoking regimens on linear...
10.
Mulroy E, Snow B, Bok A, Simpson M, Smith A, Taylor K, et al.
Parkinsonism Relat Disord
. 2020 Dec;
82:128-132.
PMID: 33321452
Introduction: In 2019, we published the results of a Phase IIb randomized controlled trial of putaminal encapsulated porcine choroid plexus cell (termed NTCELL®) administration in patients with Parkinson's disease. This...